Flow cytometry demonstrated a marked reduction in tumor-infiltrating CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> regulatory T cells, indicating modulation of the tumor immune microenvironment. The gene discussed is CD4; the disease is neoplasm.